PERCEPTIVE ADVISORS LLC 13D and 13G filings for Acrivon Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-04 4:05 pm Sale |
2025-06-02 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-3,104,139 (Position Closed) |
Filing |
| 2025-05-01 8:21 pm Sale |
2025-04-29 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
PERCEPTIVE ADVISORS LLC | 3,104,139 9.900% |
-2,256,719 (-42.10%) |
Filing |
| 2024-04-15 08:21 am Purchase |
2024-04-11 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
PERCEPTIVE ADVISORS LLC | 5,360,858 17.400% |
2,353,000 (+78.23%) |
Filing |
| 2024-02-14 4:36 pm Unchanged |
2023-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
PERCEPTIVE ADVISORS LLC | 3,007,858 13.600% |
0 (Unchanged) |
Filing |
| 2023-02-14 2:33 pm Unchanged |
2022-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
PERCEPTIVE ADVISORS LLC | 3,007,858 14.400% |
0 (Unchanged) |
Filing |
| 2022-11-18 4:31 pm Purchase |
2022-11-17 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
PERCEPTIVE ADVISORS LLC | 3,007,858 14.400% |
3,007,858 (New Position) |
Filing |